Fineline Cube

Follow:
14475 Articles
Policy / Regulatory

China’s National Health Commission Launches Three-Year Patient Safety Campaign

CompanyDrug

GluBio Pharmaceutical’s GLB-002 Receives NMPA Approval for Clinical Trials in Hematological Tumors

CompanyMedical Device

Med Vision’s Sleep Disorder Software Receives Category II Approval in China

CompanyDrug

Luye Pharma Files NDA for Paliperidone Palmitate Injectable Suspension with US FDA

Company

Apeloa Pharmaceutical Expands Global Footprint with Apeloa Europe GmbH in Germany

CompanyDeals

AbbVie Acquires Mitokinin, Advancing PINK1 Activator for Parkinson’s Disease

CompanyDrug

Shanghai BDgene’s BD112 Earns Orphan Drug Designation from US FDA for Huntington’s Disease

Company

AstraZeneca Alum Yu Yuping Appointed Vice-President at Merck KGaA’s China Unit

CompanyDeals

AffaMed Technologies Secures Exclusive Rights to SIFI’s Intraocular Lens Products in Greater China

CompanyDeals

Simcere Pharmaceutical Secures Exclusive Rights to AnDiCon’s Anti-Influenza Candidate ADC189

CompanyDrug

J&J’s Janssen Reports Favorable Spravato Data in Late-Stage TRD Trial

CompanyDeals

BMS to Acquire Mirati Therapeutics in a $4.8 Billion Deal